Exact Sciences (EXAS)
(Delayed Data from NSDQ)
$67.99 USD
-1.49 (-2.14%)
Updated Sep 17, 2024 04:00 PM ET
After-Market: $68.02 +0.03 (0.04%) 6:40 PM ET
2-Buy of 5 2
D Value A Growth C Momentum B VGM
Brokerage Reports
Exact Sciences Corporation [EXAS]
Reports for Purchase
Showing records 321 - 340 ( 371 total )
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Overcorrection, Extended Patent Protection - Upgrading Stock.
Provider: RODMAN & RENSHAW, CO.
Analyst: PIROS E
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Overcorrection, Extended Patent Protection - Upgrading Stock.
Provider: RODMAN & RENSHAW, CO.
Analyst: PIROS E
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
2Q11 Results Review: Timelines on Track; Tweaks Sample Container and Marker Panel
Provider: AURIGA USA
Analyst: MCDONALD P
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
2Q11 Results In-Line - Validation Data on Track for 4Q Release
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Fair Value Reached - Lowering Rating to Market Perform
Provider: RODMAN & RENSHAW, CO.
Analyst: PIROS E
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Fair Value Reached - Lowering Rating to Market Perform
Provider: RODMAN & RENSHAW, CO.
Analyst: PIROS E
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
2Q11 Financial Preview Reaffirming OUTPERFORM Rating Expecting Slightly Positive Test Design,
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Reaffirming OUTPERFORM Following Meetings with Management; Encouraged by CMS Dialogue Among Other Things
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z